The prevalence of HIV, TB, drug-resistant TB (DR-TB), multidrug-resistant TB (MDR-TB) and hepatitis C is alarming in the state of Manipur. As a result, co-infection is on the rise. In cases of co-infection, each disease speeds up the progress of the other, making the patient more vulnerable and the treatment more difficult. A holistic patient-centric approach can have positive outcomes.


MSF started providing specialised care for HIV and TB in Manipur in 2005 and 2007, respectively. At the clinics located in Churachandpur, Chakpikarong and Moreh (on the Indo-Myanmar border) MSF provides free, high-quality screening, diagnosis and treatment for HIV, TB, hepatitis C and co-infections

Since the treatment causes significant side effects, making it difficult for patients to adhere to their treatment regimen, MSF provides pre and post-test adherence counselling to ensure a successful outcome for the patients. The health education teams also raise awareness on getting tested and treated. MSF is also treating hepatitis C patients (mono-infected) in an opioid substitution therapy (OST) centre in Churachandpur, along with treating partners of co-infected patients.

IN 2017

MSF continued to support the TB ward and started hepatitis C treatment at the District Hospital in Churachandpur. Staff trainings were organised and for the first time, treatment for hepatitis C started at the hospital in July this year. In addition, MSF continued to provide treatment for TB, HIV, hepatitis C at all its clinics

Hepatitis C


Cases of mono-infection treated


Cases of co-infection treated



Drug-sensitive TB (DSTB) patients treated


DR-TB patients treated



Patients registered